Expression of β-catenin and cyclin D1 in epidermal stem cells of diabetic rats
Related Experiment Video
Updated: Jun 3, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Qing-Ling Zhong1, Fan-Rong Liu, De-Wu Liu
1Burns Institute, Nanchang University Medical College, Nanchang, P.R. China.
Abstract:
The healing of diabetic wounds represents a formidable clinical challenge, and the molecular mechanisms involved in diabetic wound healing are far from clear. In this study, we investigated the expression of β-catenin and cyclin D1 in the epidermal stem cells (ESCs) of diabetic rats, and explored whether the reduction of β-catenin and its downstream target in ESCs, cyclin D1, lead to poor wound healing in diabetes mellitus (DM). We found that, compared to the controls, the ESCs of diabetic rats were markedly reduced, the clone formation efficiency of the ESCs was markedly lower, and the mRNA and protein expression of β-catenin and cyclin D1 was significantly decreased. These findings suggest that the low expression of β-catenin and cyclin D1 may reduce the activity of ESCs from diabetic rats, which might be one of the important mechanisms of delayed wound healing in DM.
Insights
Diabetic wound healing is impaired due to reduced epidermal stem cell (ESC) activity. This study found lower expression of beta-catenin and cyclin D1 in diabetic rat ESCs, contributing to delayed healing in diabetes mellitus.
Area of Science:
- Biomedical research
- Molecular biology
- Wound healing research
Background:
- Diabetic wound healing presents significant clinical challenges.
- The underlying molecular mechanisms of impaired wound healing in diabetes mellitus (DM) remain unclear.
Purpose of the Study:
- To investigate the expression of beta-catenin and cyclin D1 in epidermal stem cells (ESCs) of diabetic rats.
- To explore the role of reduced beta-catenin and cyclin D1 in the poor wound healing observed in DM.
Main Methods:
- Comparative analysis of ESCs from diabetic and control rats.
- Assessment of ESC quantity, clone formation efficiency, and mRNA/protein expression levels of beta-catenin and cyclin D1.
Main Results:
- Diabetic rat ESCs were reduced in number and exhibited lower clone formation efficiency compared to controls.
- Significant decrease in both mRNA and protein expression of beta-catenin and cyclin D1 was observed in diabetic rat ESCs.
Conclusions:
- Reduced expression of beta-catenin and cyclin D1 may decrease the activity of ESCs in diabetic rats.
- This downregulation of beta-catenin and cyclin D1 is a potential key mechanism contributing to delayed wound healing in diabetes mellitus.
More Related Videos
08:06Creation and Transplantation of an Adipose-derived Stem Cell (ASC) Sheet in a Diabetic Wound-healing Model
Published on: August 4, 2017
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
Related Concept Videos
Cell Specific Gene Expression
Renewal of Skin Epidermal Stem Cells